Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin and continuous glucose monitoring in type 2 diabetes mellitus
NL-OMON37821Active, not recruiting
- Sponsor
- PRA Health Sciences
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by PRA Health Sciences. Primary endpoints: 24-hour weighted mean glucose and Hemoglobin A1c. Started Feb 2012; status: active, not recruiting.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON37821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37821.